Grant: Research Tools and Instruments
University of Toronto
$42,963.00
A fast protein liquid chromatography system for purifying prion proteins
EF 2015-16
Résumé
The presence of misfolded, aggregated proteins in the brain is a hallmark of many human neurodegenerative diseases. Of particular interest are the prion diseases, which include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE, or “mad cow disease”) in cattle. In these diseases, misshapen proteins called prions accumulate in the brain, eventually resulting in the death of brain cells. Prions are notorious for being infectious proteins. Generally, prions from one species do not efficiently infect other species, a process referred to as the “species barrier”. Sometimes, the species barrier is imperfect, as in the case of the transmission of BSE prions to humans during the mad cow disease epidemic in the United Kingdom. Some animal species, such as dogs and horses, are seemingly resistant to prion disease. At the other end of the spectrum, bank voles (Myodes glareolus) are susceptible to prions from many different species, suggesting that they do not impose a species barrier for prions. Thus, bank voles provide a unique opportunity to study the transfer of prions from one species to another. My previous work has demonstrated that bank voles produce a prion protein that is extremely susceptible to misfolding (both spontaneously and upon exposure to prions from other species). I was recently awarded an NSERC Discovery Grant to study the reasons why the bank vole prion protein is “promiscuous” for replicating prions and why it is much more prone to misfolding than prion proteins from other species. Two of the projects outlined in my grant require large amounts of purified, recombinant bank vole prion protein that has been produced in bacteria. A fast protein liquid chromatography (FPLC) system is necessary for the efficient separation of recombinant bank vole prion protein from other proteins present in the bacteria. In this RTI proposal, I am requesting funds to purchase an FPLC system so that the experiments detailed in my NSERC Discovery Grant can proceed as planned. This research will provide insight into the molecular details of prion misfolding and interspecies prion transmission.
Programme
Research Tools and Instruments
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RTI-2016-00508
Name nom
Watts, Joel
Department département
Neurodegenerative Diseases, Centre for Research in - Neurodegenerative Diseases,
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2016
Award amount
42963
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1601
Committee name en
Genes, Cells and Molecules (RTI)
Committee name fr
Gènes, cellules et molécules (OIR)
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
A fast protein liquid chromatography system for purifying prion proteins
Keyword
NSERC
Application summary
The presence of misfolded, aggregated proteins in the brain is a hallmark of many human neurodegenerative diseases. Of particular interest are the prion diseases, which include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE, or “mad cow disease”) in cattle. In these diseases, misshapen proteins called prions accumulate in the brain, eventually resulting in the death of brain cells. Prions are notorious for being infectious proteins. Generally, prions from one species do not efficiently infect other species, a process referred to as the “species barrier”. Sometimes, the species barrier is imperfect, as in the case of the transmission of BSE prions to humans during the mad cow disease epidemic in the United Kingdom. Some animal species, such as dogs and horses, are seemingly resistant to prion disease. At the other end of the spectrum, bank voles (<em>Myodes glareolus</em>) are susceptible to prions from many different species, suggesting that they do not impose a species barrier for prions. Thus, bank voles provide a unique opportunity to study the transfer of prions from one species to another. My previous work has demonstrated that bank voles produce a prion protein that is extremely susceptible to misfolding (both spontaneously and upon exposure to prions from other species). I was recently awarded an NSERC Discovery Grant to study the reasons why the bank vole prion protein is “promiscuous” for replicating prions and why it is much more prone to misfolding than prion proteins from other species. Two of the projects outlined in my grant require large amounts of purified, recombinant bank vole prion protein that has been produced in bacteria. A fast protein liquid chromatography (FPLC) system is necessary for the efficient separation of recombinant bank vole prion protein from other proteins present in the bacteria. In this RTI proposal, I am requesting funds to purchase an FPLC system so that the experiments detailed in my NSERC Discovery Grant can proceed as planned. This research will provide insight into the molecular details of prion misfolding and interspecies prion transmission.